Supplementary Figure S4 from Combining Brigatinib with mTOR Inhibition to Effectively Treat NF2-SWN–Associated and Sporadic NF2-Deficient Meningiomas

Long‐Sheng Chang; Janet L. Oblinger; Lai Man Natalie Wu; Cecelia Miller; Sarah S. Burns

doi:10.1158/2767-9764.31154394

Supplementary Figure S4 from Combining Brigatinib with mTOR Inhibition to Effectively Treat NF2-SWN–Associated and Sporadic NF2-Deficient Meningiomas

2026 Open access

Read full text

Authors: Long‐Sheng Chang, Janet L. Oblinger, Lai Man Natalie Wu, Cecelia Miller, Sarah S. Burns

DOI: 10.1158/2767-9764.31154394

Cited by: 0

Abstract

Figure S4. Analysis of the transcriptome of immortalized AG-NF2-Men cells reveals expression of several meningioma biomarkers and merlin-regulated RTKs.

Fields of Study & Subjects

Meningioma and schwannoma management Neurofibromatosis and Schwannoma Cases Glioma Diagnosis and Treatment

Publication details

Publication date: 27 January 2026